The U.S. military is expected to announce the development of a corona vaccine
The Walter Reed Research Institute is developing a vaccine against all versions of the virus, and human trials have already been completed this month. However, their effectiveness has not yet been tested on the Omicron strain which has become dominant in the US
The U.S. military is expected to announce that it has developed a vaccine against the corona virus and its various variants, Defense One reported.
US Army develops corona vaccine (Photo: US Army)
The Walter Reed Research Institute has been developing a nanoparticle vaccine, SpFN, since the beginning of 2020, and already in early April it began human trials.
WRAIT’s director of infectious diseases, Kyban Modjrad, told the newspaper that the trials ended this month and yielded positive results, which are currently being examined by various factors. “It’s very exciting to get to this point for our whole team, and I think for the whole army as well,” he said.
The news of the new vaccine comes as the omicron variant has become dominant in corona infections across the United States, having first been identified in South Africa just last month.
Experts continue to stress that vaccines and booster injections offer the best protection against the new version, and drug companies Pfizer and Moderna have said that a third dose of their vaccines significantly raises antibody levels against the new version.
(Photo: Reuters)
First, the United States Army Vaccine Report claims that it is effective against all versions, including the omicron. But a statement was later released that the vaccine’s effectiveness had not yet been tested on the new version.
“Several recent reports on the development of vaccines against the corona of the Walter Reed Research Institute have been led to inaccurate arguments that require clarification,” the statement said. “The vaccine is intended to protect against an array of versions of corona, but it has not been tested on the Omicron strain.”
The U.S. military Infectious Diseases Division added that researchers are analyzing the results of early human trials, saying the final results will be published in a journal. Modjrad said the rapid spread of the Omicron and Delta variants, as well as the increased vaccination rates, caused the early trials to take longer than expected.
Military vaccine trials required people who had not been vaccinated and had not been infected in the past in Corona. Subsequently, the vaccine will join to be tested on people who have been vaccinated in the past or have been ill in the past. “We need to assess this in the real environment, and try to understand how the vaccine works in much larger numbers of people who have already been vaccinated with another vaccine, or who have already been ill,” Modergard said.
Did the article interest you?